SCHEMBL813450

SCHEMBL813450

NC(=O)c1cc(C(N)=O)cc(C(N)=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 8/20 0.53
▸ TSHR P16473 4/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ PMP22 Q01453 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ DHODH Q02127 2/20 0.50
▸ PARP10 Q53GL7 2/20 0.46
▸ PARP4 Q9UKK3 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ PARP15 Q460N3 1/20 0.46
▸ PARP14 Q460N5 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8366010 0.87 DHODH (0.65) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL1807478 0.87 CYP3A4 (0.44) PARP1TSHRCYP3A4POLBMAPT
Ethylene Glycol SCHEMBL28673949 0.87 CYP3A4 (0.44) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL1807480 0.87 PARP1 (0.58) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL1498158 0.87 DHODH (0.65) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL1807992 0.87 KDM4E (0.46) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL31601062 0.87 DHODH (0.48) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL1807991 0.85 CYP3A4 (0.43) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL5090099 0.85 CA5A (0.52) PARP1TSHRCYP3A4POLBMAPT
SCHEMBL7077548 0.85 PARP1 (0.60) PARP1TSHRCYP3A4POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119264634-A Carbon dioxide-based PPC-P straw material and preparation method thereof 广东众塑降解材料有限公司 2025-01-07 — — CN claimed
CN-118978730-A Preparation and application of perfluorosulfonic acid ion exchange membrane 安徽海螺洁能科技有限公司 2024-11-19 — — CN claimed
EP-3578378-B1 RECORDING MEDIUM AND METHOD FOR PRODUCING RECORDING MEDIUM CANON KK (JP) 2024-08-28 — — EP claimed
CN-114410084-B Toughened polylactic acid composite material and preparation method thereof 江苏尚艾新材料科技有限公司 2024-07-05 — — CN claimed
US-20240059880-A1 METALLOCENE POLYPROPYLENE COMPOSITIONS FINA TECHNOLOGY, INC. 2024-02-22 — — US claimed
US-20240043669-A1 POLYPROPYLENE COMPOSITIONS WITH IMPROVED CLARITY FINA TECHNOLOGY, INC. 2024-02-08 — — US claimed
CN-116751430-A Self-repairing elastomer based on triple hydrogen bond and metal coordination effect and preparation method thereof 西北工业大学 2023-09-15 — — CN claimed
US-11733189-B2 Method for identifying a blend of nucleators useful for preparing a nucleated polyolefin material NJC EUROPE LIMITED (GB) 2023-08-22 — — US claimed
CN-113845770-B Composite plastic particle and preparation method thereof 上海欣洁商务服务有限公司 2023-06-27 — — CN claimed
CN-116199894-A Inner-winding chiral polymer and preparation method and application thereof 中山大学 2023-06-02 — — CN claimed
EP-2254126-A1 Organogel for electrical cable insulating layer Nexans (FR) 2010-11-24 — — EP claimed
WO-2008144119-A1 POLYPROPYLENE FILMS WITH ENHANCED MOISTURE BARRIER PROPERTIES, PROCESS FOR MAKING AND COMPOSITION THEREOF EXXONMOBIL OIL CORPORATION (US) 2008-11-27 — — WO claimed
US-20080286547-A1 Polypropylene films with enhanced moisture barrier properties, process for making and composition thereof EXXONMOBIL OIL CORPORATION 2008-11-20 — — US claimed
US-20080045638-A1 Plasticized hetero-phase polyolefin blends EXXONMOBIL CHEMICAL PATENTS INC. 2008-02-21 — — US claimed
JP-2004502669-A — — 2004-01-29 — — JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 — — EP claimed
US-20020128255-A1 Compounds to treat alzheimer's disease PHARMACIA & UPJOHN COMPANY 2002-09-12 — — US claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 — — WO claimed
US-5424349-A Tertiary amides with low volatility and good thermal stability ALBEMARLE CORPORATION (US) 1995-06-13 — — US claimed
WO-1992016495-A1 AMIDE ANTIOXIDANTS ETHYL CORPORATION (US) 1992-10-01 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128255-A1 Compounds to treat alzheimer's disease PSEN2, PSEN1, APP PARP1 2861/4885TSHR 3725/4885CYP3A4 1415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback